TIGIT / NFAT Reporter - Jurkat Cell Line

SKU:BHC18200029
Research Validated
Overview
Click light‑blue chips for details
TIGIT / NFAT Reporter - Jurkat Cell Line is a Reporter Cell Line (Jurkat background, Human origin, BSL-1) from BPS Bioscience. Designed for this cell line is ideal for high throughput screening (hts) to identify antagonistic monoclonal antibodies targeting either tigit or its ligands, such as cd155 in a cellular context. workflows.
Parental Cell Line Jurkat
Species Human
Biosafety Level BSL-1
Product Type Reporter Cell Line
Mycoplasma Tested Confirmed Negative
Storage Store in liquid nitrogen immediately upon receipt.
Available Options

Select the variant that best fits your experiment. Availability and lead time may vary by option.

  • Options: Size: 2 Vials
  • Lead time: options listed in "Availability Content"; other statuses may take longer.
  • Storage: Store in liquid nitrogen immediately upon receipt.
  • Shipping: cold-chain shipment (typically with ice packs).
  • Upon receipt: store at the recommended temperature as soon as possible.
  • Sales terms and conditions: Please review prior to ordering.
Options selector
Catalog no. Size
60538 2 Vials
Field Specification
Alternative Names T-cell immunoreceptor with Ig and ITIM domains, V-set and immunoglobulin domain-containing protein 9, VSIG9, V-set and transmembrane domain-containing protein 3, VSTM3
Product Type
  • Reporter Cell Line
Shipping -80°C (dry ice)
Species Human
Storage Store in liquid nitrogen immediately upon receipt.

Scientific Background

TIGIT is a co-inhibitory receptor that is highly expressed in Natural Killer (NK) cells, activated CD4+, CD8+ and regulatory T cells. Interaction with the poliovirus receptor (PVR; CD155) on antigen presenting cells, such as dendritic cells, recruits Src homology (SH) domain-containing protein tyrosine phosphatase SHP1 and SHP2 or the inositol phosphatase SHIP1 and SHIP2 to the TIGIT ITIM domain. This increases IL-10 release and suppresses NF-kB and NFAT T cell receptor (TCR) signaling, which blocks T cell proliferation and cytokine production. It serves as a competitive inhibitor of CD226, a co-stimulatory receptor for CD155. TIGIT targeting antibodies that block this T cell-intrinsic inhibitory effects have shown enhanced anti-tumor and anti-viral functions in preclinical studies.

Product Description

Immunotherapy Immune Checkpoints

Recombinant Jurkat cell line constitutively expressing a full length human TIGIT (T cell Immunoreceptor with Immunoglobulin and ITIM domain; VSTM3), and a firefly luciferase gene under the control of nuclear factor of activator T cells (NFAT) response element. Both TIGIT and NFAT constructs have been stably integrated into Jurkat cells. TIGIT expression has been confirmed by Western Blot, and TIGIT-specific NFAT response has been validated using a TIGIT ligand, CD155 (PVR).

Product Specifications

Host Cell Line Jurkat
Host Species Human
Transfection Method Electroporation
Format Aqueous solution containing DMSO
Harmonized Tariff Code 3002-5900

Quality Control & Validation

✓ Mycoplasma-Tested

This cell line has been screened using the MycoAlert™ Mycoplasma Detection Kit (Lonza, Cat. #LT07-118) to confirm the absence of Mycoplasma contamination. MycoAlert Assay Control Set (Lonza, Cat. #LT07-518) was used as a positive control.

Usage Notes

See product datasheet for detailed protocol.

Safety & Handling

⚠ Avoid freeze/thaw cycles.

Regulatory Information

License RequiredYes
Living Modified OrganismYes

License Disclosure

Purchase of this cell line grants you with a 10-year license to use this cell line in your immediate laboratory, for research use only. This license does not permit you to share, distribute, sell, sublicense, or otherwise make the cell line available for use to other laboratories, departments, research institutions, hospitals, universities, or biotech companies. The license does not permit use of this cell line in humans or for therapeutic or drug use. The license does not permit modification of the cell line in any way. Inappropriate use or distribution of this cell line will result in revocation of the license and result in an immediate cease of sales and distribution of BPS products to your laboratory. BPS does not warrant the suitability of the cell line for any particular use, and does not accept any liability in connection with the handling or use of the cell line. Modifications of this cell line, transfer to another facility, or commercial use of the cells may require a separate license and additional fees; contact sales@bpsbioscience.com for details. Publications using this cell line should reference BPS Bioscience, Inc., San Diego.

Related Products

Related Products: Cat. #71251, 72029, 72030, 60537, 60190, 60690, 60184, 79796

Required Accessories: Cat. #60190,60690,60184,79796

What is the parental cell line for this product?

This product is engineered on a Jurkat background (Human origin). The Jurkat host was selected for its compatibility with stable transfection and the target pathway or assay type. Consult the product datasheet for passage number guidance and recommended culture media.

What biosafety level is required for this cell line?

This product is classified as BSL-1. Standard microbiological practices (gloves, lab coat, eye protection) are sufficient. No specialized containment facility is required beyond a clean bench. Consult your institutional IBC for GMO registration requirements.

Has this cell line been tested for mycoplasma contamination?

Yes. This cell line has been screened using the MycoAlert™ Mycoplasma Detection Kit (Lonza, Cat. #LT07-118) to confirm the absence of Mycoplasma contamination. MycoAlert Assay Control Set (Lonza, Cat. #LT07-518) was used as a positive control. We recommend that you independently confirm mycoplasma-negative status after receipt and periodically during routine culture using a validated detection kit.

What are the recommended storage conditions?

Store this product at Liquid Nitrogen. Specifically: Store in liquid nitrogen immediately upon receipt. Transfer cells from dry-ice shipping to the recommended storage immediately upon receipt. Avoid repeated freeze-thaw cycles, which reduce viability and may alter expression characteristics.

Is a license required to use this product?

Yes, a license is required (Yes). Purchase of this cell line grants a time-limited research-use license for use in your immediate laboratory only. This license does not permit redistribution, sub-licensing, transfer to other institutions, or commercial use. Refer to the License Disclosure section on this page or contact BPS Bioscience for details regarding modifications or commercial licensing.

What method was used to generate this cell line?

This stable cell line was generated using Electroporation for transgene delivery into the parental host. The stably integrated cells were selected using the appropriate resistance marker and verified for expression prior to cryopreservation.

Can't find the cell line you need—or require a custom engineered model for your study? We offer end-to-end support for diverse research needs, including:

  • Cell line sourcing and selection (species, tissue, and disease model matching)
  • Stable cell line engineering (overexpression, knockdown, knockout via CRISPR/Cas9, shRNA, sgRNA)
  • Reporter gene integration (GFP, RFP, luciferase, fluorescent/bioluminescent constructs)
  • Genome editing and knockin (point mutations, tagged endogenous proteins, conditional alleles)
  • Inducible expression systems (Tet-On/Off and regulatable constructs)
  • Drug resistance marker selection (puromycin, G418, hygromycin, and others)
  • Custom growth and media optimisation for specific assay requirements
  • Scale-up production for high-throughput screening campaigns
  • Authentication and QC services (STR profiling, mycoplasma testing, viability assessment)

Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.

  1. Li M et.al (2014) T-cell Immunoglobulin and ITIM Domain (TIGIT) Receptor/ Poliovirus Receptor (PVR) Ligand Engagement Suppresses Interferon-g Production of Natural Killer Cells via b-arrestin 2-mediated Negative Signaling. J Biol Chem. 289: 17647-17657.
  2. Stanietsky N. et.al. (2009) The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity. PNAS. 106: 17858-17863.
  3. Zhu et.al. (2016) Identification of CD112R as a novel checkpoint for human T cells. J Exp. Med. 213: 167-176.
  4. Yu X. et.al. (2008) The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. Nat.Immunol. 10: 48-57.

Research budgets are tight — we get it. That's why we've put together a fresh round of exclusive promotions designed to help you stock up on the reagents, kits, and consumables your lab depends on, without stretching your budget.

🔬 What's on offer right now:

10% Off Pre-Designed siRNA Sets

20% Off Transmembrane Proteins

$50 Off All ELISA Kits

50% Off Lab Consumables + Free Shipping

$99 Pipette Filler Promotion Package

BlasTaq 2X qPCR MasterMix - 50% OFF Limited Time Offer

DENARASE® Endonuclease — 10% Off One Order

10% OFF CELL LINES-Limited-Time Offer

15% Off Proteins from Trusted Suppliers — Limited Time

👉 Browse all current deals

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Supplier Ads Slides show

Add dynamic ads with slider